• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂暴露与急性呼吸衰竭患者住院死亡率的倾向评分匹配分析。

A propensity score-matching analysis of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker exposure on in-hospital mortality in patients with acute respiratory failure.

机构信息

Laboratory of Molecular Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

Laboratory of Medical Molecular Imaging, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.

出版信息

Pharmacotherapy. 2022 May;42(5):387-396. doi: 10.1002/phar.2677. Epub 2022 Apr 8.

DOI:10.1002/phar.2677
PMID:35344607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9322533/
Abstract

STUDY OBJECTIVE

To explore the impact of pre-hospital ACEI and ARB exposure on the prognosis of ARF patients.

DESIGN

A single-center retrospective cohort study.

SETTING

Medical Information Mart for Intensive Care-III (MIMIC-III) database.

PATIENTS

The patients meeting ICD-9 code of acute respiratory failure were enrolled.

INTERVENTION

The primary exposure was the pre-hospital exposure of ACEI and ARB.

MEASUREMENT AND MAIN RESULTS

The primary outcome was in-hospital mortality. Multiple logistic regression analysis was conducted to determine the independent effect of ACEI/ARB exposure on mortality. Propensity score matching (PSM) method was adopted to reduce bias of the confounders. Subgroup analysis and sensitivity analysis were used to test the stability of the conclusion. 5335 adult ARF patients were enrolled. Mortality was significantly decreased in patients with ACEI/ARB exposure before and after PSM, and the adjusted odds ratio (OR) of ACEI/ARB exposure was 0.56 (95% CI 0.43-0.72). In the subgroup analysis, ACEI/ARB lost its protective effect in young subgroup, but no significant interaction was found between ACEI/ARB exposure and age (p = 0.082). The point estimation and lower 95% limit of E-value was 2.97 and 2.12. In sensitivity analysis, ACEI/ARB exposure showed similar effect in ARDS cohort, but no significantly difference was found in the MIMIC-IV database, which may be explained by small sample size of the ACEI/ARB group.

CONCLUSIONS

Among patients with acute respiratory failure, pre-hospital ACEI/ARB exposure was associated with better outcomes and acted as an independent factor. The relationship between ACEI/ARB and prognosis of ARF is worth investigating further.

摘要

研究目的

探讨院前 ACEI 和 ARB 暴露对急性肾损伤(ARF)患者预后的影响。

设计

单中心回顾性队列研究。

设置

医疗信息集市重症监护 III 版(MIMIC-III)数据库。

患者

纳入符合急性呼吸衰竭 ICD-9 编码的患者。

干预

主要暴露因素为 ACEI 和 ARB 的院前暴露。

测量和主要结果

主要结局为院内死亡率。采用多因素逻辑回归分析确定 ACEI/ARB 暴露对死亡率的独立影响。采用倾向评分匹配(PSM)方法减少混杂因素的偏差。采用亚组分析和敏感性分析来检验结论的稳定性。共纳入 5335 例成年 ARF 患者。PSM 前后 ACEI/ARB 暴露患者死亡率显著降低,ACEI/ARB 暴露的调整后比值比(OR)为 0.56(95%CI 0.43-0.72)。亚组分析显示,ACEI/ARB 在年轻亚组中丧失了保护作用,但 ACEI/ARB 暴露与年龄之间未发现显著交互作用(p=0.082)。E 值的点估计值和下限 95%置信区间分别为 2.97 和 2.12。敏感性分析显示,ACEI/ARB 暴露在 ARDS 队列中具有相似的效果,但在 MIMIC-IV 数据库中未发现显著差异,这可能是由于 ACEI/ARB 组的样本量较小所致。

结论

在急性呼吸衰竭患者中,院前 ACEI/ARB 暴露与更好的结局相关,是一个独立的影响因素。ACEI/ARB 与 ARF 预后之间的关系值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e844/9322533/afbf2bae7abf/PHAR-42-387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e844/9322533/f307914bd99c/PHAR-42-387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e844/9322533/1df2cb0eb130/PHAR-42-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e844/9322533/afbf2bae7abf/PHAR-42-387-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e844/9322533/f307914bd99c/PHAR-42-387-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e844/9322533/1df2cb0eb130/PHAR-42-387-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e844/9322533/afbf2bae7abf/PHAR-42-387-g003.jpg

相似文献

1
A propensity score-matching analysis of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker exposure on in-hospital mortality in patients with acute respiratory failure.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂暴露与急性呼吸衰竭患者住院死亡率的倾向评分匹配分析。
Pharmacotherapy. 2022 May;42(5):387-396. doi: 10.1002/phar.2677. Epub 2022 Apr 8.
2
The Association of Renin-Angiotensin System Blockades and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Acute Respiratory Failure: A Retrospective Cohort Study.肾素-血管紧张素系统阻滞剂与慢性阻塞性肺疾病急性加重合并急性呼吸衰竭患者死亡率的相关性:一项回顾性队列研究。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 1;17:2001-2011. doi: 10.2147/COPD.S370817. eCollection 2022.
3
Effect of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on In-Hospital Outcomes Based on Renal Function Among Critically Ill Patients: Findings From the Medical Information Mart for Intensive Care IV Database.基于危重症患者肾功能的血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂对住院结局的影响:来自重症监护信息集市 IV 数据库的研究结果。
J Clin Pharmacol. 2023 Dec;63(12):1344-1351. doi: 10.1002/jcph.2302. Epub 2023 Jul 24.
4
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.住院 COVID-19 合并高血压患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的住院使用率与死亡率的关系。
Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17.
5
Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.血管紧张素转换酶抑制或血管紧张素受体阻断对透析患者的影响:一项全国性数据调查与倾向分析
Medicine (Baltimore). 2015 Jan;94(3):e424. doi: 10.1097/MD.0000000000000424.
6
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.基于左心室射血分数的肾素-血管紧张素系统阻断对急性冠状动脉综合征预后的影响
Rev Esp Cardiol (Engl Ed). 2020 Feb;73(2):114-122. doi: 10.1016/j.rec.2019.02.012. Epub 2019 May 17.
7
Effect of pre-transplantation use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in kidney transplant recipients-propensity score-matched analysis.肾移植受者移植前使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂的效果-倾向评分匹配分析。
J Nephrol. 2024 Jul;37(6):1589-1597. doi: 10.1007/s40620-024-01938-3. Epub 2024 Apr 29.
8
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂的使用与急性肾损伤后结局的关系。
JAMA Intern Med. 2018 Dec 1;178(12):1681-1690. doi: 10.1001/jamainternmed.2018.4749.
9
End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study.使用血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的终末期肾病患者可能降低死亡风险:一项台湾全国性队列研究。
Intern Med J. 2018 Sep;48(9):1123-1132. doi: 10.1111/imj.13971.
10
Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂对亚洲人新发糖尿病发病率的影响
Yonsei Med J. 2016 Jan;57(1):180-6. doi: 10.3349/ymj.2016.57.1.180.

引用本文的文献

1
Prognostic impact of angiotensin-converting enzyme inhibitors and dexmedetomidine in acute respiratory distress syndrome: a MIMIC-IV-based retrospective cohort analysis.血管紧张素转换酶抑制剂和右美托咪定对急性呼吸窘迫综合征的预后影响:基于MIMIC-IV的回顾性队列分析
Front Med (Lausanne). 2025 Aug 18;12:1601565. doi: 10.3389/fmed.2025.1601565. eCollection 2025.
2
Competing risk analysis of dexmedetomidine use and postoperative outcomes in non-traumatic subarachnoid hemorrhage patients.右美托咪定在非创伤性蛛网膜下腔出血患者中的使用与术后结局的竞争风险分析
Eur J Med Res. 2025 Jul 30;30(1):688. doi: 10.1186/s40001-025-02962-0.
3

本文引用的文献

1
A trauma-related survival predictive model of acute respiratory distress syndrome.创伤相关的急性呼吸窘迫综合征生存预测模型。
J Clin Lab Anal. 2021 Nov;35(11):e24006. doi: 10.1002/jcla.24006. Epub 2021 Sep 20.
2
Mortality prediction for patients with acute respiratory distress syndrome based on machine learning: a population-based study.基于机器学习的急性呼吸窘迫综合征患者死亡率预测:一项基于人群的研究。
Ann Transl Med. 2021 May;9(9):794. doi: 10.21037/atm-20-6624.
3
The Association Between the Baseline and the Change in Neutrophil-to-Lymphocyte Ratio and Short-Term Mortality in Patients With Acute Respiratory Distress Syndrome.
Association between blood urea nitrogen to albumin ratio and 28-day mortality in ICU patients with acute respiratory failure: a retrospective analysis of MIMIC-IV database.
急性呼吸衰竭重症监护病房患者血尿素氮与白蛋白比值与28天死亡率的关联:MIMIC-IV数据库的回顾性分析
BMC Med Inform Decis Mak. 2025 Jul 6;25(1):253. doi: 10.1186/s12911-025-03100-w.
4
Association between serum direct bilirubin and 90-day mortality in patients with ARDS: A retrospective analysis.急性呼吸窘迫综合征患者血清直接胆红素与90天死亡率的相关性:一项回顾性分析。
Medicine (Baltimore). 2025 Jun 27;104(26):e43051. doi: 10.1097/MD.0000000000043051.
5
The association between the use of angiotensin-converting enzyme inhibitors /angiotensin receptor blockers and the development of ventilator-associated pneumonia in the intensive care unit: a retrospective cohort study.血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂的使用与重症监护病房呼吸机相关性肺炎发展之间的关联:一项回顾性队列研究。
BMC Pulm Med. 2024 Nov 21;24(1):578. doi: 10.1186/s12890-024-03386-y.
6
Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients.不同单一及联合降压药物治疗方案对重症监护患者死亡率的影响。
Front Pharmacol. 2024 Aug 28;15:1385397. doi: 10.3389/fphar.2024.1385397. eCollection 2024.
7
Association of red cell distribution width and its changes with the 30-day mortality in patients with acute respiratory failure: An analysis of MIMIC-IV database.红细胞分布宽度及其变化与急性呼吸衰竭患者 30 天死亡率的关系:对 MIMIC-IV 数据库的分析。
PLoS One. 2023 Nov 3;18(11):e0293986. doi: 10.1371/journal.pone.0293986. eCollection 2023.
8
The impact of aspirin exposure prior to intensive care unit admission on the outcomes for patients with sepsis-associated acute respiratory failure.重症监护病房入院前使用阿司匹林对脓毒症相关性急性呼吸衰竭患者预后的影响。
Front Pharmacol. 2023 Mar 1;14:1125611. doi: 10.3389/fphar.2023.1125611. eCollection 2023.
急性呼吸窘迫综合征患者中性粒细胞与淋巴细胞比值的基线水平及变化与短期死亡率之间的关联
Front Med (Lausanne). 2021 May 14;8:636869. doi: 10.3389/fmed.2021.636869. eCollection 2021.
4
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对血管紧张素转换酶2水平的影响:基于动物研究的综合分析
Front Pharmacol. 2021 Mar 8;12:619524. doi: 10.3389/fphar.2021.619524. eCollection 2021.
5
Association of outpatient ACE inhibitors and angiotensin receptor blockers and outcomes of acute respiratory illness: a retrospective cohort study.门诊使用血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂与急性呼吸道疾病结局的相关性:一项回顾性队列研究。
BMJ Open. 2021 Mar 17;11(3):e044010. doi: 10.1136/bmjopen-2020-044010.
6
Association Between Obesity and Short-And Long-Term Mortality in Patients With Acute Respiratory Distress Syndrome Based on the Berlin Definition.基于柏林定义的肥胖与急性呼吸窘迫综合征患者短期和长期死亡率的相关性研究。
Front Endocrinol (Lausanne). 2021 Feb 12;11:611435. doi: 10.3389/fendo.2020.611435. eCollection 2020.
7
Red blood cell distribution width is associated with mortality risk in patients with acute respiratory distress syndrome based on the Berlin definition: A propensity score matched cohort study.基于柏林定义,红细胞分布宽度与急性呼吸窘迫综合征患者的死亡风险相关:一项倾向评分匹配队列研究。
Heart Lung. 2020 Sep-Oct;49(5):641-645. doi: 10.1016/j.hrtlng.2020.04.008. Epub 2020 May 17.
8
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts.人心脏中假定的新型冠状病毒受体血管紧张素转换酶2的细胞类型特异性表达。
Eur Heart J. 2020 May 14;41(19):1804-1806. doi: 10.1093/eurheartj/ehaa311.
9
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?新型冠状病毒肺炎与血管紧张素转换酶抑制剂及血管紧张素受体阻滞剂:证据是什么?
JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812.
10
A new method for identifying the acute respiratory distress syndrome disease based on noninvasive physiological parameters.一种基于无创生理参数的急性呼吸窘迫综合征疾病识别新方法。
PLoS One. 2020 Feb 5;15(2):e0226962. doi: 10.1371/journal.pone.0226962. eCollection 2020.